The Director of Acceleron Pharma Inc. (NASDAQ:XLRN), Jean George, completed a three day stock sale transaction yesterday, in which he unloaded a total of 25,477 shares of Common Stock. The sale was initiated this past Friday, when George sold the minor amount of 1,457 shares, indirectly, at a price of $35.02 per share. On Monday the transaction was continued by unloading 13,618 shares, indirectly, at $35.27 per share, to be completed yesterday with the sale of another 10,402 shares, for $35.03 per share. After the sale, the Director of the biopharmaceutical firm holds a total of 1.913,554 shares.
While stock sales have been common throughout June at Acceleron, the latest insider purchase, dating back to May 5th of this year was impressive, with shareholder Corp de Celgene purchasing 1.1 million shares for $42.86 per share. Furthermore, hedge funds like Adage Capital Management, run by Phill Gross and Robert Atchinson, remain strong in their shareholder position, with 1.3 million shares, worth $46.3 million.
Disclosure: none
